FDA approves first generic RECTIV ointment by Cosette Pharmaceuticals
In a landmark move for the pharmaceutical industry, Cosette Pharmaceuticals, Inc. has received approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Applications (ANDA) for the first generic version of RECTIV (nitroglycerin) ointment, 0.4%. This approval not only marks a significant milestone for Cosette but also triggers a 180-day Competitive […]